ASO Author Reflections: Prediction of Morbidity and Mortality After Esophagectomy: A Systematic Review.
作者信息
van Nieuw Amerongen M P, de Grooth H J, Veerman G L, Ziesemer K A, van Berge Henegouwen M I, Tuinman P R
机构信息
Department of Adult Intensive Care Medicine, Amsterdam UMC (VUmc), Amsterdam, The Netherlands.
Medical Library, Vrije Universiteit, Amsterdam, The Netherlands.
出版信息
Ann Surg Oncol. 2024 May;31(5):3471-3472. doi: 10.1245/s10434-024-15089-z. Epub 2024 Mar 7.
Abstract
摘要
相似文献
1
ASO Author Reflections: Prediction of Morbidity and Mortality After Esophagectomy: A Systematic Review.美国外科医师学会（ASO）作者反思：食管癌切除术后发病率和死亡率的预测：一项系统评价。
Ann Surg Oncol. 2024 May;31(5):3471-3472. doi: 10.1245/s10434-024-15089-z. Epub 2024 Mar 7.
2
ASO Author Reflections: Quality Improvement in Minimally Invasive Esophagectomy.ASO作者反思：微创食管切除术的质量改进
Ann Surg Oncol. 2019 Jan;26(1):188-189. doi: 10.1245/s10434-018-7079-0. Epub 2018 Nov 26.
3
Prediction of Morbidity and Mortality After Esophagectomy: A Systematic Review.食管癌手术后发病率和死亡率的预测：系统评价。
Ann Surg Oncol. 2024 May;31(5):3459-3470. doi: 10.1245/s10434-024-14997-4. Epub 2024 Feb 21.
4
ASO Author Reflections: Does Thoracic Duct Resection Impact Long-Term Survival After Esophagectomy?ASO作者反思：胸导管切除术对食管癌切除术后的长期生存有影响吗？
Ann Surg Oncol. 2024 Oct;31(10):6710-6711. doi: 10.1245/s10434-024-15857-x. Epub 2024 Jul 17.
5
ASO Author Reflections: Surgical Resection of Esophageal Neuroendocrine Tumors Should Be Considered as an Integral Part of Multimodal Therapy in Localized Disease.ASO作者反思：食管神经内分泌肿瘤的手术切除应被视为局限性疾病多模式治疗的一个组成部分。
Ann Surg Oncol. 2020 Mar;27(3):681-682. doi: 10.1245/s10434-019-08058-4. Epub 2019 Nov 18.
6
Risk and Complication Management in Esophageal Cancer Surgery: A Review of the Literature.食管癌手术中的风险与并发症管理：文献综述
Thorac Cardiovasc Surg. 2016 Oct;64(7):596-605. doi: 10.1055/s-0034-1399763. Epub 2015 Jan 28.
7
ASO Author Reflections: More May Not Be Better.反义寡核苷酸作者反思：更多未必更好。
Ann Surg Oncol. 2020 Feb;27(2):509-510. doi: 10.1245/s10434-019-08021-3. Epub 2019 Oct 31.
8
9
ASO Author Reflections: Survival Outcomes of Patients with Esophageal Cancer and Post-chemoradiotherapy Surgical T4b Disease: Is Palliative Resection Justified?ASO作者反思：食管癌患者及放化疗后手术T4b期疾病的生存结果：姑息性切除是否合理？
Ann Surg Oncol. 2024 Oct;31(10):6712-6713. doi: 10.1245/s10434-024-15607-z. Epub 2024 Jun 13.
10
ASO Author Reflections: Prognostic Stratification and the Value of Adjuvant Therapy in Thoracic Esophageal Squamous Cell Carcinoma Patients After Esophagectomy.ASO作者反思：胸段食管鳞状细胞癌患者食管切除术后的预后分层及辅助治疗的价值
Ann Surg Oncol. 2019 Dec;26(Suppl 3):802-803. doi: 10.1245/s10434-019-07728-7. Epub 2019 Oct 25.
本文引用的文献
1
Risk Prediction Model of 90-Day Mortality After Esophagectomy for Cancer.食管癌切除术 90 天后死亡率的风险预测模型。
JAMA Surg. 2021 Sep 1;156(9):836-845. doi: 10.1001/jamasurg.2021.2376.
2
Esophageal Cancer: An Updated Review.食管癌：更新综述。
South Med J. 2021 Mar;114(3):161-168. doi: 10.14423/SMJ.0000000000001226.
3
NTCP model for postoperative complications and one-year mortality after trimodality treatment in oesophageal cancer.多模式治疗食管癌术后并发症和 1 年死亡率的 NTCP 模型。
Radiother Oncol. 2019 Dec;141:33-40. doi: 10.1016/j.radonc.2019.09.015. Epub 2019 Oct 17.
4
A risk model for esophagectomy using data of 5354 patients included in a Japanese nationwide web-based database.一项利用日本全国性网络数据库中5354例患者的数据建立的食管癌切除术风险模型。
Ann Surg. 2014 Aug;260(2):259-66. doi: 10.1097/SLA.0000000000000644.
Zotero 插件